Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generalised uridine diphosphate galactose-4-epimerase deficiency.

J H Walter1, R E Roberts, G T Besley

  • 1Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital, Pendlebury, Manchester M27 4HA, UK. john@jhwalter.demon.co.uk

Archives of Disease in Childhood
|March 23, 1999
PubMed
Summary

Generalised epimerase deficiency galactosaemia is rare, affecting only a few children. Affected individuals experience poor growth, learning difficulties, and developmental issues despite treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in England.

Molecular genetics and metabolism·2019
Same author

The complete European guidelines on phenylketonuria: diagnosis and treatment.

Orphanet journal of rare diseases·2017
Same author

Erratum to: Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

JIMD reports·2016
Same author

Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

JIMD reports·2016
Same author

Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation.

JIMD reports·2016
Same author

Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential.

Osteoarthritis and cartilage·2015

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Epimerase deficiency galactosaemia is a rare metabolic disorder.
  • The generalised form is exceptionally rare, with limited documented cases.

Observation:

  • This study reports on five children from two families with generalised epimerase deficiency galactosaemia.
  • Initial symptoms mimicked classic galactosaemia.

Findings:

  • Despite treatment, all affected children exhibited poor growth and moderate learning difficulties.
  • Sensorineural deafness was observed in three children, and pronounced dysmorphic features in four.
  • The two oldest female patients achieved normal pubertal development.

Implications:

Related Experiment Videos

  • This highlights the severe long-term challenges associated with generalised epimerase deficiency galactosaemia.
  • Early diagnosis and intervention are crucial, though outcomes remain poor.
  • Further research into management strategies and potential therapies is warranted.